A detailed history of Truist Financial Corp transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 53,250 shares of MDXG stock, worth $484,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,250
Previous 53,250 -0.0%
Holding current value
$484,575
Previous $369,000 14.91%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

BUY
$6.16 - $8.08 $215,600 - $282,800
35,000 Added 191.78%
53,250 $369,000
Q1 2023

May 05, 2023

SELL
$2.97 - $4.81 $2,227 - $3,607
-750 Reduced 3.95%
18,250 $62,000
Q2 2022

Jul 22, 2022

SELL
$3.17 - $5.0 $4,057 - $6,400
-1,280 Reduced 6.31%
19,000 $66,000
Q3 2021

Nov 05, 2021

SELL
$5.52 - $15.83 $1,380 - $3,957
-250 Reduced 1.22%
20,280 $123,000
Q2 2021

Aug 16, 2021

BUY
$9.02 - $12.72 $11,545 - $16,281
1,280 Added 6.65%
20,530 $257,000
Q4 2020

Feb 18, 2021

BUY
$5.32 - $10.17 $102,410 - $195,772
19,250 New
19,250 $175,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.